FIND DOCTORS
-
Name: Wu, hongbin
Department: PHARMACY
Title:Associate chief pharmacistEducation & Professional Experience 2001- Associate chief pharmacist, Department of Pharmacy, Fudan University Cancer Hospital.
1996-2001 Pharmacist, Department of Pharmacy, Fudan University Cancer Hospital.
1990-1996 Pharmacist, Department of Pharmacy, Fudan University Cancer Hospital.
1985-1990 B.S. College of Pharmacy, Shanghai Medical University.
Specialty Pharmacy Research Pharmacy Publication A class：2 papers
1. Wu Hongbin 1，Xu Litao2, Meng Zhiqiang2 .Experimental study of anticancer mechanism of Jianpiliqi Granules in H22 hepatic cancer mice[J]. China Journal of Traditional Chinese medicine and pharmacy , 2011,26(1)。
2. Wu Hongbin 1，Xu Litao2, Meng Zhiqiang2 .The pharmacodynamics research of the anticancer effect of Jianpiliqi granules with different extracting techniques in H22 hepatic cancer mice[J]. China Journal of Traditional Chinese medicine and pharmacy , 2011,26(4)。
B class：8 papers
1. Wu Hongbin,Lu Yi,Lu Guochun. Adverse effects and precaution of imatinib mesylate[J]. Chinese Journal of New Drugs, 2006，15（22）：1923-1925.
2．Liu Jiawei，Ling Yunhua，Lu Yi，Wu Hongbin*. The adverse reactions and management of irinotecan [J]. Chinese Journal of New Drugs, 2007, 16（17）：1355-1356.
3．Qiu Yanbing,Ling yunhua,Wu hongbin*,et al.Utilization of chinese herbal medicines in our hospital during 2004-2006 [J]. Evaluation and Analysis of Drug-use in Hospital of China, 2008, 8（1）：31-32.
4. Ling Yunhua，Wu Hongbin*，Wu Wei,et al. Evaluation of adverse events of oral capecitabine in 119 patients [J]. Evaluation and Analysis of Drug-use in Hospitals of China, 2008, 8（3）：224-226.
5．Ling Yunhua,Shen Min,Wu Hongbin*,et al.Outpatient use of fentanyl transdermal system in our hospital during the period 2006-2007[J]. Evaluation and Analysis of Drug-use in Hospitals of China, 2008, 8（4）：274-276.
6．Ling Yunhua,Wu Hongbin*,Lu Yi,et,al.Influence factors on cisplatin inhibiting tumor in vitro [J]. Chinese Journal of Clinical Pharmacy, 2008, 17(4):6-7.
7．Wu Hongbin ，Cheng Lin ，Meng Zhiqiang. Therapeutic effect observation of Fufangdangshenbaishu Granules on primary liver cancer [J]. Evaluation and Analysis of Drug-use in Hospitals of China, 2009, 9（3）：218-220.
8．Zhang Juan，Wu Hongbin*，Zhai Qing. The rcent clinical research status of trastuzumab(herceptin) for the treatment of patients with Her-2-overexpression gastric cancer [J]. Evaluation and Analysis of Drug-use in Hospitals of China, 2010, 10（5）：390-392.
Awards N/A Out-patient Schedule N/A
